leucine has been researched along with Lower Extremity Weakness, Spastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brice, A; Campion, D; Durr, A; Frebourg, T; Hahn, V; Jacquemont, ML; Tallaksen, C | 1 |
1 other study(ies) available for leucine and Lower Extremity Weakness, Spastic
| Article | Year |
|---|---|
Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Substitution; Dementia; Genetic Predisposition to Disease; Humans; Leucine; Male; Membrane Proteins; Middle Aged; Mutation; Paraparesis, Spastic; Presenilin-1; Proline | 2002 |